Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07301229
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Shanghai Henlius Biotech 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07336953
What this trial is testing

A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
West China Hospital 198
Testing effectiveness (Phase 2)Looking for participantsNCT07640295
What this trial is testing

Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Jacobio Pharmaceuticals Co., Ltd. 80
Not applicableStudy completedNCT06336694
What this trial is testing

A Deep Learning Radiomics Model for Predicting Occult Peritoneal Metastases of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Neoplasms
First Affiliated Hospital, Sun Yat-Sen University 302
Large-scale testing (Phase 3)UnknownNCT00005870
What this trial is testing

Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Not applicableLooking for participantsNCT05475366
What this trial is testing

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures

Who this might be right for
Carcinoma, Pancreatic DuctalPrognosis
Institut Curie 85
Not applicableEnded earlyNCT03397342
What this trial is testing

MRI Only Radiation Therapy With CPAP

Who this might be right for
Carcinoma LiverCarcinoma, Pancreatic
Albert Einstein College of Medicine 5
Testing effectiveness (Phase 2)Study completedNCT00089024
What this trial is testing

Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Nebraska 29
Early research (Phase 1)Active Not RecruitingNCT03257761
What this trial is testing

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct Adenocarcinoma, Biliary TypeGallbladder Adenocarcinoma, Biliary TypeMetastatic Pancreatic Adenocarcinoma+25 more
University of Southern California 55
Testing effectiveness (Phase 2)Ended earlyNCT00466856
What this trial is testing

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Who this might be right for
Head and Neck CancerIslet Cell TumorMetastatic Cancer+1 more
Vanderbilt-Ingram Cancer Center 10
Early research (Phase 1)Not Yet RecruitingNCT06217666
What this trial is testing

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

Who this might be right for
Pancreatic Adenocarcinoma
Haoming (Carl) Qiu 24
Early research (Phase 1)Study completedNCT01839981
What this trial is testing

CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Wake Forest University Health Sciences 10
Testing effectiveness (Phase 2)Ended earlyNCT00613730
What this trial is testing

Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint

Who this might be right for
Cancer of PancreasCancer of the PancreasPancreas Cancer+1 more
Amgen 3
Not applicableLooking for participantsNCT07340151
What this trial is testing

Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Adenocarcinoma of the Pancreas
The University of Texas Health Science Center at San Antonio 40
Testing effectiveness (Phase 2)Ended earlyNCT02921737
What this trial is testing

TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)

Who this might be right for
Pancreatic Cancer
University of Florida 7
Testing effectiveness (Phase 2)Study completedNCT00016965
What this trial is testing

BMS-247550 in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Ended earlyNCT05546411
What this trial is testing

A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer

Who this might be right for
Pancreatic CancerResectable Pancreatic CancerBorderline Resectable Pancreatic Adenocarcinoma+1 more
Kimberly Perez, MD 8
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Early research (Phase 1)Not Yet RecruitingNCT07348107
What this trial is testing

ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Advanced Pancreatic Ductal Adenocarcinoma
Daniel Breadner 10
Testing effectiveness (Phase 2)UnknownNCT05627427
What this trial is testing

Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy

Who this might be right for
Neuroendocrine Tumor Grade 3Neuroendocrine CarcinomaPancreatic Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Next Page